Whom we work with.

Remedy is proud to count many of the most sophisticated employers in the world as our clients. Whether they are big or small, public or private, new or established, they all agree on one thing: improving health results begins by taking charge of your medication data.

It’s your health. Own it.


Financial Services








See who is talking about us.

ViacomCBS Inc. Case Study

ViacomCBS Inc. has engaged Remedy to extract medication-centric claims from both the health plan and the PBM, so these otherwise-disparate data sets could all be integrated and analyzed. The result is a successful conversion into actionable information to improve the outcomes for both benefit plans and create cost efficiencies to be measured and managed ongoing.

Contact us to see how you can do the same for your business.

Contact Remedy

We put PharmaLogic® and our specialists
to work for you!

Benefits executives work hard trying to manage the health of their employees and their dependents, while also controlling costs for both them and the employer-sponsor.

Unfortunately, it seems the prescription drug industry desires opacity and the status quo, working hard to keep data out of the hands of these professionals so that they simply can’t make informed decisions. Remedy, by unleashing the power of PharmaLogic®, removes the industry obfuscation and puts the unbiased facts and measurable evidence onto plan sponsors’ desktops so intelligent decisions
can be made that produce clear, proven results.

- Scott Kelly, COO | Aspire Health Plan

As a commercial and government health plan, Remedy is an invaluable partner to our organization. Remedy’s analytics and technology allow us to see inside our PBM claims data to expose what would otherwise be hidden. My team and I are comprised of executive industry veterans and medical directors, and that experience has solidified the importance of partnering with innovative technology, especially in the PBM space, notorious for its complexity. Remedy’s breadth and depth of knowledge in the pharmaceutical realm, their analytic toolset, as well as positive working relationships with our team have demonstrated we made the right choice.”